Clinic
Epic Care
Epic Care was paid $17.79M by Medicaid between Feb 2018 and Dec 2024, across 87 billing codes. Its largest line is 78815, Positron emission tomography (PET) for limited area imaging — 19% of everything it billed.
33Billing provider infoEPIC CARE
ANTIOCH, CA 94531
ANTIOCH, CA 94531
33aNPI1780107797assigned 07/21/2017
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$17.79M
24GClaims237,475
24DCodes billed87
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in California
Rank by total paid#8 of 170
Median peer was paid$145K
This provider vs. median123×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,333 | $500K | |
| 2019 | 25,109 | $1.15M | |
| 2020 | 25,914 | $1.97M | |
| 2021 | 36,498 | $2.47M | |
| 2022 | 36,987 | $2.53M | |
| 2023 | 47,449 | $4.18M | |
| 2024incomplete | 49,185 | $4.99M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 78815 | Positron emission tomography (PET) for limited area imaging | 19% | 3,081 | 2,378 | $3.43M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 54,841 | 51,331 | $3.12M |
| J0897 | Injection, denosumab, 1 mg | 6.3% | 776 | 755 | $1.11M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.5% | 12,214 | 4,464 | $982K |
| 77014 | 4.5% | 8,746 | 1,666 | $799K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.4% | 8,836 | 7,618 | $781K |
| J1453 | Injection, fosaprepitant, 1 mg | 4.4% | 1,811 | 1,193 | $776K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.0% | 16,709 | 16,242 | $714K |
| J9271 | Injection, pembrolizumab, 1 mg | 3.7% | 160 | 124 | $655K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.2% | 10,390 | 6,472 | $572K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 2.3% | 1,880 | 1,057 | $401K |
| 99223 | Prolong inpt eval add15 m | 2.2% | 2,752 | 2,693 | $384K |
75 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 2,097 | $321K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 1.7% | 1,116 | $302K |
| 99205 | Prolong outpt/office vis | 1.5% | 2,814 | $273K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.5% | 4,897 | $273K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.5% | 4,113 | $268K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1.3% | 1,907 | $231K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1.1% | 4,408 | $201K |
| 96367 | <1% | 8,098 | $177K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 2,122 | $175K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 28,994 | $169K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,856 | $165K |
| 77427 | <1% | 958 | $134K | |
| 77336 | <1% | 1,592 | $132K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18,781 | $123K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,339 | $120K |
| 77334 | <1% | 540 | $108K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 64 | $105K |
| 77280 | <1% | 341 | $72K | |
| 77300 | <1% | 599 | $69K | |
| J0641 | Injection, levoleucovorin, not otherwise specified, 0.5 mg | <1% | 23 | $58K |
| J1437 | Injection, ferric derisomaltose, 10 mg | <1% | 26 | $52K |
| 77049 | <1% | 262 | $51K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,739 | $48K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 217 | $47K |
| G6012 | Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | <1% | 181 | $42K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 508 | $35K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | <1% | 119 | $30K |
| 96368 | <1% | 4,213 | $30K | |
| 96417 | <1% | 1,310 | $30K | |
| 99497 | <1% | 470 | $30K | |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | <1% | 137 | $24K |
| 31231 | <1% | 106 | $23K | |
| J0185 | Injection, aprepitant, 1 mg | <1% | 37 | $22K |
| 76642 | <1% | 264 | $13K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,023 | $10K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,630 | $10K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 257 | $10K |
| 96523 | <1% | 862 | $10K | |
| 31575 | <1% | 66 | $9K | |
| 80053 | Comprehensive metabolic panel | <1% | 920 | $7K |
| 95251 | <1% | 708 | $6K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 652 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 961 | $4K |
| 96415 | <1% | 164 | $4K | |
| 99443 | <1% | 145 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 205 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 381 | $4K |
| 82728 | <1% | 150 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 14 | $2K |
| 93000 | <1% | 125 | $2K | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 48 | $2K |
| 96411 | <1% | 39 | $2K | |
| 47562 | <1% | 12 | $2K | |
| 83615 | <1% | 305 | $1K | |
| 77263 | <1% | 16 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 18 | $1K |
| 71250 | <1% | 43 | $1K | |
| 69210 | <1% | 26 | $1K | |
| 84550 | <1% | 270 | $961.56 | |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 25 | $910.33 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 361 | $848.22 |
| 92552 | <1% | 52 | $839.01 | |
| 99354 | <1% | 12 | $596.64 | |
| 85018 | <1% | 450 | $506.48 | |
| 82948 | <1% | 308 | $342.77 | |
| 83540 | <1% | 43 | $298.34 | |
| 83735 | <1% | 31 | $202.77 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 35 | $142.96 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 28 | $125.86 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 18 | $117.95 |
| J3490 | Unclassified drugs | <1% | 88 | $109.75 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $73.59 |
| 81000 | <1% | 15 | $58.05 | |
| 96402 | <1% | 12 | $48.98 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 501 | $39.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPATEL, BIMAL (PRESIDENT)